Clinical Trial Update: Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated BI 1744 CL in chronic obstructive pulmonary disease and has completed with results posted. The study assessed safety and efficacy of BI …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BI 1744 CL

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-06-05